Jessie Bourcier

519 total citations
12 papers, 204 citations indexed

About

Jessie Bourcier is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Jessie Bourcier has authored 12 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Jessie Bourcier's work include Multiple Myeloma Research and Treatments (4 papers), Acute Myeloid Leukemia Research (3 papers) and Protein Degradation and Inhibitors (3 papers). Jessie Bourcier is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Acute Myeloid Leukemia Research (3 papers) and Protein Degradation and Inhibitors (3 papers). Jessie Bourcier collaborates with scholars based in France, United States and Canada. Jessie Bourcier's co-authors include Philippe Moreau, Cyrille Touzeau, Benoît Tessoulin, Sophie Maïga, Martine Amiot, Patricia Gomez‐Bougie, Steven Le Gouill, Catherine Pellat‐Deceunynck, Anne Lok and Beatrice Mahé and has published in prestigious journals such as Blood, Annals of Oncology and Leukemia.

In The Last Decade

Jessie Bourcier

10 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessie Bourcier France 7 96 88 80 33 29 12 204
Esperanza Lavilla Spain 8 65 0.7× 100 1.1× 82 1.0× 11 0.3× 20 0.7× 12 200
Juan Manuel Alonso‐Domínguez Spain 10 78 0.8× 58 0.7× 106 1.3× 22 0.7× 9 0.3× 40 242
Katarzyna Jamieson United States 9 131 1.4× 90 1.0× 191 2.4× 9 0.3× 11 0.4× 22 267
Uroš Markovic Italy 8 60 0.6× 41 0.5× 95 1.2× 21 0.6× 24 0.8× 36 188
Kota Yoshifuji Japan 6 111 1.2× 53 0.6× 57 0.7× 45 1.4× 17 0.6× 28 208
M.-P. Pagès France 7 73 0.8× 31 0.4× 91 1.1× 9 0.3× 10 0.3× 14 196
Afshin Eli Gabayan United States 6 83 0.9× 80 0.9× 82 1.0× 27 0.8× 13 0.4× 10 170
Patti Byron United States 6 112 1.2× 129 1.5× 263 3.3× 6 0.2× 19 0.7× 8 359
Olga Samoylova Russia 5 54 0.6× 100 1.1× 78 1.0× 25 0.8× 25 0.9× 16 186
Rebeca Rodríguez‐Veiga Spain 10 147 1.5× 117 1.3× 171 2.1× 38 1.2× 36 1.2× 39 326

Countries citing papers authored by Jessie Bourcier

Since Specialization
Citations

This map shows the geographic impact of Jessie Bourcier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessie Bourcier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessie Bourcier more than expected).

Fields of papers citing papers by Jessie Bourcier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessie Bourcier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessie Bourcier. The network helps show where Jessie Bourcier may publish in the future.

Co-authorship network of co-authors of Jessie Bourcier

This figure shows the co-authorship network connecting the top 25 collaborators of Jessie Bourcier. A scholar is included among the top collaborators of Jessie Bourcier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessie Bourcier. Jessie Bourcier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bewersdorf, Jan Philipp, Maximilian Stahl, Justin Taylor, et al.. (2023). E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial. Leukemia. 37(12). 2512–2516. 36 indexed citations
2.
Bourcier, Jessie, Simon J. Hogg, Caroline Erickson, et al.. (2022). Attenuation of Graft-Versus-Host-Disease Via Genetic or Pharmacologic Inhibition of the RNA Splicing Factor RBM39. Blood. 140(Supplement 1). 1163–1164.
3.
Bewersdorf, Jan Philipp, Maximilian Stahl, Justin Taylor, et al.. (2022). A Phase II Clinical Trial of E7820 for Patients with Relapsed/Refractory Myeloid Malignancies with Mutations in Splicing Factor Genes. Blood. 140(Supplement 1). 9065–9067. 4 indexed citations
4.
Wang, Eric, Jose Mario Bello Pineda, Jessie Bourcier, et al.. (2021). Modulation of RNA Splicing Enhances Response to BCL2 Inhibition in Acute Myeloid Leukemia. Blood. 138(Supplement 1). 507–507. 2 indexed citations
5.
Sesques, Pierre, Jessie Bourcier, Camille Golfier, et al.. (2020). Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era. Hematological Oncology. 38(2). 137–145. 4 indexed citations
6.
Gomez‐Bougie, Patricia, Sophie Maïga, Benoît Tessoulin, et al.. (2018). BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment. Blood. 132(25). 2656–2669. 62 indexed citations
7.
8.
Bourcier, Jessie, Thomas Gastinne, Christophe Leux, et al.. (2016). Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience. Annals of Hematology. 95(8). 1287–1293. 9 indexed citations
9.
Mahé, Beatrice, Nicolas Blin, Viviane Dubruille, et al.. (2015). Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study. Annals of Oncology. 27(2). 314–318. 31 indexed citations
10.
11.
Bourcier, Jessie & Stéphanie Guidez. (2014). 1st World Congress on Controversies in Multiple Myeloma (COMy) Bangkok, May 11-13 2014. Hématologie. 20(5). 276–283.
12.
Tomiak, Anna, Jonathan C. Yau, S. Huan, et al.. (1994). Duration of intravenous antibiotics for patients with neutropenic fever. Annals of Oncology. 5(5). 441–445. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esperanza Lavilla Breakdown of academic impact, for papers by Juan Manuel Alonso‐Domínguez Breakdown of academic impact, for papers by Katarzyna Jamieson Breakdown of academic impact, for papers by Uroš Markovic Breakdown of academic impact, for papers by Kota Yoshifuji Breakdown of academic impact, for papers by M.-P. Pagès Breakdown of academic impact, for papers by Afshin Eli Gabayan Breakdown of academic impact, for papers by Patti Byron Breakdown of academic impact, for papers by Olga Samoylova Breakdown of academic impact, for papers by Rebeca Rodríguez‐Veiga
Rankless by CCL
2026